| Antimicrobial Resistance in Developing Countries: Challenges in Medicine Development and Policy Implementation |
| Paper ID : 1202-IGA |
| Authors |
|
Ahmad Shafizadeh * Faculty of Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, Iran |
| Abstract |
| Antimicrobial resistance (AMR) has become a global health crisis, with developing countries facing the most severe consequences due to limited resources, inadequate healthcare infrastructure, and weak regulatory frameworks. The misuse and overuse of antibiotics, poor sanitation, and insufficient surveillance systems exacerbate the spread of resistant pathogens, posing a significant threat to public health. This review explores the key challenges in medicine development and policy implementation related to AMR in developing nations. It examines barriers such as the high cost of research and development, lack of investment in novel antibiotics, and the difficulties in enforcing antimicrobial stewardship programs. Additionally, potential solutions, including strengthening healthcare policies, enhancing global collaborations, and promoting the development of affordable and effective antimicrobial agents, are discussed. Addressing AMR requires a coordinated effort among governments, healthcare providers, and the pharmaceutical industry to ensure sustainable and equitable access to antimicrobial treatments. Addressing AMR requires a coordinated effort among governments, healthcare providers, and the pharmaceutical industry to ensure sustainable and equitable access to antimicrobial treatments. |
| Keywords |
| Antimicrobial resistance, developing countries, healthcare policy, antibiotic misuse, medicine development, global health, infectious diseases, drug regulation, public health challenges |
| Status: Accepted |
